| Trial ID: | L5490 |
| Source ID: | NCT02587975
|
| Associated Drug: |
Evogliptin
|
| Title: |
Effect of Evogliptin on Bone Metabolism in Human
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Osteoporosis
|
| Interventions: |
DRUG: Evogliptin
|
| Outcome Measures: |
Primary: Serum concentration of C-terminal telopeptide after treatment in comparison with the baseline, Predose and 1, 2, 3, 4, 6, 14, 20, 24 h postdose on Day 1 and Day 2 |
|
| Sponsor/Collaborators: |
Sponsor: DongGuk University
|
| Gender: |
FEMALE
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2016-06
|
| Completion Date: |
2017-03
|
| Results First Posted: |
|
| Last Update Posted: |
2016-07-25
|
| Locations: |
Dongguk University Ilsan Hospital, Goyang, Gyeonggi, 410-773, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02587975
|
